Literature DB >> 12522133

p21-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling.

Lorena A Puto1, Kersi Pestonjamasp, Charles C King, Gary M Bokoch.   

Abstract

A variety of intracellular signaling pathways are linked to cell surface receptor signaling through their recruitment by Src homology 2 (SH2)/SH3-containing adapter molecules. p21-activated kinase 1 (PAK1) is an effector of Rac/Cdc42 GTPases that has been implicated in the regulation of cytoskeletal dynamics, proliferation, and cell survival signaling. In this study, we describe the specific interaction of PAK1 with the Grb2 adapter protein both in vitro and in vivo. We identify the site of this interaction as the second proline-rich SH3 binding domain of PAK1. Stimulation of the epidermal growth factor receptor (EGFR) in HaCaT cells enhances the level of EGFR-associated PAK1 and Grb2, although the PAK1-Grb2 association is itself independent of this stimulation. A cell-permeant TAT-tagged peptide encompassing the second proline-rich SH3 binding domain of PAK1 simultaneously blocked Grb2 and activated EGFR association with PAK1, in vitro and in vivo, indicating that Grb2 mediates the interaction of PAK1 with the activated EGFR. Blockade of this interaction decreased the epidermal growth factor-induced extension of membrane lamellae. Thus Grb2 may serve as an important mechanism for linking downstream PAK signaling to various upstream pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522133     DOI: 10.1074/jbc.M208414200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Constitutive p21-activated kinase (PAK) activation in breast cancer cells as a result of mislocalization of PAK to focal adhesions.

Authors:  Mary R Stofega; Luraynne C Sanders; Elisabeth M Gardiner; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

Review 2.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 3.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

4.  Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome.

Authors:  Satu Kärkkäinen; Marita Hiipakka; Jing-Huan Wang; Iivari Kleino; Marika Vähä-Jaakkola; G Herma Renkema; Michael Liss; Ralf Wagner; Kalle Saksela
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

5.  Rho GTPase protein expression and activation in murine monocytes/macrophages is not modulated by model biomaterial surfaces in serum-containing in vitro cultures.

Authors:  M L Godek; J A Sampson; N L Duchsherer; Q McElwee; D W Grainger
Journal:  J Biomater Sci Polym Ed       Date:  2006       Impact factor: 3.517

6.  Autophosphorylation-dependent degradation of Pak1, triggered by the Rho-family GTPase, Chp.

Authors:  Monika Weisz Hubsman; Natalia Volinsky; Edward Manser; Deborah Yablonski; Ami Aronheim
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

Review 7.  Virus entry by macropinocytosis.

Authors:  Jason Mercer; Ari Helenius
Journal:  Nat Cell Biol       Date:  2009-05       Impact factor: 28.824

8.  Dissecting activation of the PAK1 kinase at protrusions in living cells.

Authors:  Maria Carla Parrini; Jacques Camonis; Michiyuki Matsuda; Jean de Gunzburg
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

9.  Redesign of the PAK1 autoinhibitory domain for enhanced stability and affinity in biosensor applications.

Authors:  Ramesh K Jha; Yi I Wu; Jon S Zawistowski; Chris MacNevin; Klaus M Hahn; Brian Kuhlman
Journal:  J Mol Biol       Date:  2011-08-24       Impact factor: 5.469

10.  Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist.

Authors:  Alessio Giubellino; Zhen-Dan Shi; Lisa M Miller Jenkins; Karen M Worthy; Lakshman K Bindu; Gagani Athauda; Benedetta Peruzzi; Robert J Fisher; Ettore Appella; Terrence R Burke; Donald P Bottaro
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.